Literature DB >> 21447110

Neuropsychiatric symptoms of progressive supranuclear palsy in a dementia clinic.

Yusuke Yatabe1, Mamoru Hashimoto, Keiichirou Kaneda, Kazuki Honda, Yusuke Ogawa, Seiji Yuuki, Shiho Matsuzaki, Atsuko Tuyuguchi, Hiroko Kashiwagi, Manabu Ikeda.   

Abstract

BACKGROUND: Progressive supranuclear palsy (PSP) is a neurodegenerative disease characterized by supranuclear gaze palsy, postural instability, akinesia and other parkinsonism. Recently, the relationship between PSP and frontotemporal dementia (FTD) has been recognized, which includes clinical, pathological, biochemical and genetic features. However, there have been few studies that directly compared neuropsychiatric symptoms between PSP and FTD. The aim of the present study was to investigate comprehensive psychiatric and behavioural symptoms in PSP and compared them with those in FTD.
METHODS: Patients with PSP (n = 10) and FTD (n = 13) were selected on the basis of inclusion/exclusion criteria from a consecutive series in the dementia clinic of Kumamoto University Hospital. We assessed their comprehensive neuropsychiatric features by using the Neuropsychiatric Inventory (NPI), the Stereotypy Rating Inventory (SRI) and a specific antisocial behaviour checklist.
RESULTS: There were no significant differences in the total NPI and NPI subscale scores between the two groups. Both groups showed quite a similar pattern in the features of neuropsychiatric symptoms: apathy showed the highest score, followed by aberrant motor behaviour and disinhibition. The PSP group was significantly lower in the total SRI and eating and cooking behaviour scores than those in the FTD group. The prevalence of antisocial behaviours in PSP (50%) was equal to those in the FTD group (46%).
CONCLUSIONS: In a dementia clinic, the neuropsychiatric profile in patients with PSP closely resembled those in the FTD group. The present results suggest that PSP should be considered as not only a movement disorder, but also a disorder with a wide range of neuropsychiatric symptoms.
© 2011 The Authors. Psychogeriatrics © 2011 Japanese Psychogeriatric Society.

Entities:  

Mesh:

Year:  2011        PMID: 21447110     DOI: 10.1111/j.1479-8301.2010.00352.x

Source DB:  PubMed          Journal:  Psychogeriatrics        ISSN: 1346-3500            Impact factor:   2.440


  7 in total

1.  Parkinsonism and frontotemporal dementia: the clinical overlap.

Authors:  Alberto J Espay; Irene Litvan
Journal:  J Mol Neurosci       Date:  2011-09-03       Impact factor: 3.444

2.  The role of 18F-FP-CIT PET in differentiation of progressive supranuclear palsy and frontotemporal dementia in the early stage.

Authors:  Han Soo Yoo; Seok Jong Chung; Soo-Jong Kim; Jung Su Oh; Jae Seung Kim; Byoung Seok Ye; Young Ho Sohn; Phil Hyu Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-05-04       Impact factor: 9.236

3.  Argyrophilic grain disease as a neurodegenerative substrate in late-onset schizophrenia and delusional disorders.

Authors:  Shigeto Nagao; Osamu Yokota; Chikako Ikeda; Naoya Takeda; Hideki Ishizu; Shigetoshi Kuroda; Koichiro Sudo; Seishi Terada; Shigeo Murayama; Yosuke Uchitomi
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-11-23       Impact factor: 5.270

4.  Reorganisation of brain networks in frontotemporal dementia and progressive supranuclear palsy.

Authors:  Laura E Hughes; Boyd C P Ghosh; James B Rowe
Journal:  Neuroimage Clin       Date:  2013       Impact factor: 4.881

5.  Daily functioning and dementia.

Authors:  Gabriele Cipriani; Sabrina Danti; Lucia Picchi; Angelo Nuti; Mario Di Fiorino
Journal:  Dement Neuropsychol       Date:  2020 Apr-Jun

6.  Prevalence, associations, and predictors of apathy in adult survivors of infantile (<5 years of age) posterior fossa brain tumors.

Authors:  Cliodhna Carroll; Peter Watson; Helen A Spoudeas; Michael M Hawkins; David A Walker; Isabel C H Clare; Anthony J Holland; Howard A Ring
Journal:  Neuro Oncol       Date:  2013-03-15       Impact factor: 12.300

Review 7.  Neuropsychiatric disturbances in atypical parkinsonian disorders.

Authors:  Daniele Belvisi; Isabella Berardelli; Antonio Suppa; Andrea Fabbrini; Massimo Pasquini; Maurizio Pompili; Giovanni Fabbrini
Journal:  Neuropsychiatr Dis Treat       Date:  2018-10-09       Impact factor: 2.570

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.